Infusion Pump Market by Product (Accessories and Consumables, and Devices), Application (Oncology, Diabetes, Gastroenterology, Pain Management, Pediatrics, Hematology, and Others), End Use (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes, and Others): Global Market Size Estimates and Forecast (2022-2030)

The market is expected to cross the US$ 9.79 billion mark in 2022 and is expected to hit US$ 19.67 billion by 2030, recording a CAGR of 9.1% during the forecast period.

The infusion Pump market has been significantly growing with the rising incidence of chronic diseases.

The rising prevalence of chronic diseases worldwide creates ample opportunities for the market to grow. For instance, the International Diabetes Federation (IDF) Diabetes Atlas, 2021 statistics reported that approximately 537 million adults (aged 20-79 years) had diabetes in 2021. Thus, with the rise in diabetic cases, there is an increased need for insulin pumps, which drives the market's growth. Similarly, a chemotherapy infusion pump is recommended for patients with metastatic colorectal cancer that has spread to the liver. For instance, according to the GLOBOCAN 2020 statistics, there were 1.15 million new cases of colon cancer 2020 worldwide, and this number is expected to reach 1.92 million by the year 2040. Thus, increasing cancer cases will also drive the growth of infusion pumps during the forecast period.

Within the report, the market is segmented into product, application, end-user, and geography. Based on product, the global infusion pumps market is segmented into accessories & consumables, and devices. The market is segmented based on application: oncology, diabetes, gastroenterology, pain management, pediatrics, hematology, and others. Based on end users, the market is segmented into hospitals, home care settings, ambulatory care settings, academic and research institutes, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, Rest of World.

The advancement in technology will empower the growth of futuristic innovations.

Technological advancements in innovating products to meet safety requirements and increase the adoption of devices are likely to fuel market growth. For instance, in august 2022, Baxter Announced the U.S. FDA Clearance of Novum IQ Syringe Infusion Pump with Dose IQ Safety Software. The Novum IQ SYR can fully integrate with hospital electronic medical records (EMRs) through Baxter's IQ Enterprise Connectivity Suite. Also, the development of infusion pump devices by the key market players is propelling the growth of this market. For instance, in February 2021, Mindray Medical launched BeneFusion E series-ESP, EVP, and EDS, new infusion systems for expanding its product portfolio.

Volumetric infusion pump is one of the segment accelerating the market growth.

Volumetric infusion pumps have wide applications in disease management and parenteral nutrition. The safety, accuracy, and simplicity of infusion pumps in treating many therapeutic areas contribute to the high demand for these pumps . Moreover, market value for volumetric infusion pumps is the highest in overall infusion pumps due to  its widespread usage in various applications, technical advantages, and product launches in developing and developed countries.  In March 2022, Fresenius Kabi received regulatory clearance from the United States Food and Drug Administration (USFDA) for its wireless Agilia connect infusion system, which includes the Agilia syringe pump and Agilia volumetric pump with vigilant software suite-Vigilant Master Med technology.

Recent strategic developments in the infusion pump market

The infusion pump market has undergone several significant developments, and a few of these have been mentioned below:

• In Feb 2021, B. Braun Medical Inc. (B. Braun), received award for their Infusomat Space Large Volume Pump in KLAS for Traditional Smart Pumps category. 
• In May 2021, Smiths Medical entered into exclusive partnership with Ivenix, Inc. that positions the company as the first in the U.S. to offer a comprehensive suite of infusion management solutions to meet healthcare needs across the continuum of care.
• In August 2022, Insulet Corporation received clearance from the U.S. Food and Drug Administration (FDA) for its Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes

Several players drive the infusion pump market by implementing strategic investments, new launches, mergers & acquisitions, and partnerships. BD, Baxter, B. Braun, Smiths Medical, Medtronic, Terumo Corporation, F. Hoffmann-La Roche Ltd.; Moog Inc, Avanos Medical, Inc.; and  Insulet Corporation, are among the prominent players operating in the market.

The target audience for the report:

• Raw material providers
• Related service providers
• Related associations, organizations, forums, and alliances
• Government bodies, such as regulating authorities and policymakers
• End users
• Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

• Product:
  • Accessories and Consumables
  • Devices
• Application
  • Oncology
  • Diabetes
  • Gastroenterology
  • Pain Management
  • Pediatrics
  • Hematology
  • Others
• End-user:
  • Hospitals
  • Home Care Settings
  • Ambulatory Care Settings
  • Academic and Research Institutes
  • Others
• Region
  • North America
  • Europe
  • Asia Pacific (APAC)
  • South & Central America
  • Middle East & Africa
• Companies profiled
  • BD
  • Baxter
  • B. Braun
  • Smiths Medical
  • Medtronic
  • Terumo Corporation
  • F. Hoffmann-La Roche Ltd
  • Moog Inc
  • Avanos Medical, Inc.
  • Insulet Corporation

The List of Companies
- BD
- Baxter
- B. Braun
- Smiths Medical
- Medtronic
- Terumo Corporation
- F. Hoffmann-La Roche Ltd
- Moog Inc
- Avanos Medical, Inc.
- Insulet Corporation